This case tells the story of Hey Jane, a telehealth clinic founded in 2020 that provides virtual medication abortion services to eligible patients in nine U.S. states. By January 2023, the company had served more than 20,000 patients and raised nearly $10 million in venture capital, all while navigating an ever-evolving regulatory landscape. At the time of the case, Kiki Freedman, Hey Jane's CEO and founder, is considering expanding the company's holistic support model to another highly stigmatized reproductive health need-maternal mental health.